Search

Your search keyword '"Oliveira, Ana C. A."' showing total 7 results
Start Over Author "Oliveira, Ana C. A." Database OAIster
7 results on '"Oliveira, Ana C. A."'

1. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

Author

AbbVie Pharmaceuticals, European Commission, Chatzikonstantinou, Thomas, Scarfò, Lydia, Karakatsoulis, Georgios, Minga, Eva, Chamou, Dimitra, Iacoboni, Gloria, Kotaskova, Jana, Demosthenous, Christos, Smolej, Lukas, Mulligan, Stephen, Alcoceba, Miguel, Kreitman, Robert J., Labrador, Jorge, Lad, Deepesh, Levin, Mark-David, Levy, Ilana, Longval, Thomas, López-García, Alberto, Marquet, Juan, Martín-Rodríguez, Lucía, Maynadié, Marc, Tadmor, Tamar, Maslejova, Stanislava, Mayor-Bastida, Carlota, Mihaljevic, Biljana, Milosevic, Ivana, Mirás, Fátima, Moia, Riccardo, Morawska, Marta, Murru, Roberta, Nath, Uttam Kumar, Navarro-Bailón, Almudena, Tomic, Kristina, Oliveira, Ana C., Olivieri, Jacopo, Oscier, David, Panovska-Stavridis, Irina, Papaioannou, María, Papajík, Tomás, Kubova, Zuzana, Phumphukhieo, Punyarat, Pierie, Cheyenne, Puiggros, Anna, Tse, Eric, Rani, Lata, Reda, Gianluigi, Rigolin, Gian Matteo, Ruchlemer, Rosa, Daniel de Deus Santos, Marcos, Schipani, Mattia, Schiwitza, Annett, Shen, Yandong, Simkovic, Martín, Smirnova, Svetlana, Vassilakopoulos, Theodoros, Abdelrahman Soliman, Dina Sameh, Spacek, Martin, Visentin, Andrea, Vitale, Candida, von Tresckow, Julia, Vrachiolias, George, Vukovic, Vojin, Walewska, Renata, Al-Shemari, Salem, Wasik-Szczepanek, Ewa, Xu, Zhenshu, Yagci, Munci, Yañez, Lucrecia, Yassin, Mohamed, Zuchnicka, Jana, Angelopoulou, Maria, Antic, Darko, Biderman, Bella, Catherwood, Mark, Aurran-Schleinitz, Thérèse, Claus, Rainer, Coscia, Marta, Cuneo, Antonio, Demirkan, Fatih, Espinet, Blanca, Gaidano, Gianluca, Kalashnikova, Olga B., Laurenti, Luca, Nikitin, Eugene, Pangalis, Gerassimos A., Bacchiarri, Francesca, Panagiotidis, Panagiotis, Popov, Viola María, Pospisilova, Sarka, Sportoletti, Paolo, Stavroyianni, Niki, Tam, Constantine S., Trentin, Livio, Chatzidimitriou, Anastasia, Bosch, Francesc, Doubek, Michael, Bellido, Mar, Ghia, Paolo, Stamatopoulos, Kostas, Bijou, Fontanet, Calleja, Anne, Medina, Angeles, Khan, Mehreen Ali, Cassin, Ramona, Chatzileontiadou, Sofía, Collado, Rosa, Christian, Amy, Davis, Zadie, Dimou, María, Donaldson, David, Santos, Gimena Dos, Dreta, Bárbara, Efstathopoulou, María, El-Ashwah, Shaimaa, Enrico, Alicia, Fresa, Alberto, Galimberti, Sara, Galitzia, Andrea, García-Serra, Rocío, Gimeno, Eva, González-Gascón y Marín, Isabel, Gozzetti, Alessandro, Guarente, Valerio, Guieze, Romain, Gogia, Ajay, Gupta, Ritu, Harrop, Sean, Hatzimichael, Eleftheria, Herishanu, Yair, Hernández-Rivas, José Ángel, Inchiappa, Luca, Jaksic, Ozren, Janssen, Susanne, Kalicińska, Elżbieta, Kamel, Laribi, Karakus, Volkan, Kater, Arnon P., Kho, Bonnie, Kislova, María, Konstantinou, Eliana, Koren-Michowitz, Maya, Kotsianidis, Ioannis, AbbVie Pharmaceuticals, European Commission, Chatzikonstantinou, Thomas, Scarfò, Lydia, Karakatsoulis, Georgios, Minga, Eva, Chamou, Dimitra, Iacoboni, Gloria, Kotaskova, Jana, Demosthenous, Christos, Smolej, Lukas, Mulligan, Stephen, Alcoceba, Miguel, Kreitman, Robert J., Labrador, Jorge, Lad, Deepesh, Levin, Mark-David, Levy, Ilana, Longval, Thomas, López-García, Alberto, Marquet, Juan, Martín-Rodríguez, Lucía, Maynadié, Marc, Tadmor, Tamar, Maslejova, Stanislava, Mayor-Bastida, Carlota, Mihaljevic, Biljana, Milosevic, Ivana, Mirás, Fátima, Moia, Riccardo, Morawska, Marta, Murru, Roberta, Nath, Uttam Kumar, Navarro-Bailón, Almudena, Tomic, Kristina, Oliveira, Ana C., Olivieri, Jacopo, Oscier, David, Panovska-Stavridis, Irina, Papaioannou, María, Papajík, Tomás, Kubova, Zuzana, Phumphukhieo, Punyarat, Pierie, Cheyenne, Puiggros, Anna, Tse, Eric, Rani, Lata, Reda, Gianluigi, Rigolin, Gian Matteo, Ruchlemer, Rosa, Daniel de Deus Santos, Marcos, Schipani, Mattia, Schiwitza, Annett, Shen, Yandong, Simkovic, Martín, Smirnova, Svetlana, Vassilakopoulos, Theodoros, Abdelrahman Soliman, Dina Sameh, Spacek, Martin, Visentin, Andrea, Vitale, Candida, von Tresckow, Julia, Vrachiolias, George, Vukovic, Vojin, Walewska, Renata, Al-Shemari, Salem, Wasik-Szczepanek, Ewa, Xu, Zhenshu, Yagci, Munci, Yañez, Lucrecia, Yassin, Mohamed, Zuchnicka, Jana, Angelopoulou, Maria, Antic, Darko, Biderman, Bella, Catherwood, Mark, Aurran-Schleinitz, Thérèse, Claus, Rainer, Coscia, Marta, Cuneo, Antonio, Demirkan, Fatih, Espinet, Blanca, Gaidano, Gianluca, Kalashnikova, Olga B., Laurenti, Luca, Nikitin, Eugene, Pangalis, Gerassimos A., Bacchiarri, Francesca, Panagiotidis, Panagiotis, Popov, Viola María, Pospisilova, Sarka, Sportoletti, Paolo, Stavroyianni, Niki, Tam, Constantine S., Trentin, Livio, Chatzidimitriou, Anastasia, Bosch, Francesc, Doubek, Michael, Bellido, Mar, Ghia, Paolo, Stamatopoulos, Kostas, Bijou, Fontanet, Calleja, Anne, Medina, Angeles, Khan, Mehreen Ali, Cassin, Ramona, Chatzileontiadou, Sofía, Collado, Rosa, Christian, Amy, Davis, Zadie, Dimou, María, Donaldson, David, Santos, Gimena Dos, Dreta, Bárbara, Efstathopoulou, María, El-Ashwah, Shaimaa, Enrico, Alicia, Fresa, Alberto, Galimberti, Sara, Galitzia, Andrea, García-Serra, Rocío, Gimeno, Eva, González-Gascón y Marín, Isabel, Gozzetti, Alessandro, Guarente, Valerio, Guieze, Romain, Gogia, Ajay, Gupta, Ritu, Harrop, Sean, Hatzimichael, Eleftheria, Herishanu, Yair, Hernández-Rivas, José Ángel, Inchiappa, Luca, Jaksic, Ozren, Janssen, Susanne, Kalicińska, Elżbieta, Kamel, Laribi, Karakus, Volkan, Kater, Arnon P., Kho, Bonnie, Kislova, María, Konstantinou, Eliana, Koren-Michowitz, Maya, and Kotsianidis, Ioannis

Abstract

[Background]: Patients with chronic lymphocytic leukemia (CLL) have a higher risk of developing other malignancies (OMs) compared to the general population. However, the impact of CLL-related risk factors and CLL-directed treatment is still unclear and represents the focus of this work., [Methods]: We conducted a retrospective international multicenter study to assess the incidence of OMs and detect potential risk factors in 19,705 patients with CLL, small lymphocytic lymphoma, or high-count CLL-like monoclonal B-cell lymphocytosis, diagnosed between 2000 and 2016. Data collection took place between October 2020 and March 2022., [Findings]: In 129,254 years of follow-up after CLL diagnosis, 3513 OMs were diagnosed (27.2 OMs/1000 person-years). The most common hematological OMs were Richter transformation, myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Non-melanoma skin (NMSC) and prostate cancers were the most common solid tumors (STs). The only predictor for MDS and AML development was treatment with fludarabine and cyclophosphamide with/without rituximab (FC ± R) (OR = 3.7; 95% CI = 2.79–4.91; p < 0.001). STs were more frequent in males and patients with unmutated immunoglobulin heavy variable genes (OR = 1.77; 95% CI = 1.49–2.11; p < 0.001/OR = 1.89; 95% CI = 1.6–2.24; p < 0.001). CLL-directed treatment was associated with non-melanoma skin and prostate cancers (OR = 1.8; 95% CI = 1.36–2.41; p < 0.001/OR = 2.11; 95% CI = 1.12–3.97; p = 0.021). In contrast, breast cancers were more frequent in untreated patients (OR = 0.17; 95% CI = 0.08–0.33; p < 0.001). Patients with CLL and an OM had inferior overall survival (OS) than those without. AML and MDS conferred the worst OS (p < 0.001)., [Interpretation]: OMs in CLL impact on OS. Treatment for CLL increased the risk for AML/MDS, prostate cancer, and NMSC. FCR was associated with increased risk for AML/MDS.

Published
2023

2. Efficacy of whole-body vibration training on brain-derived neurotrophic factor, clinical and functional outcomes, and quality of life in women with fibromyalgia syndrome: a randomized controlled trial

Author

Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., Taiar, Redha, Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., and Taiar, Redha

Abstract

Whole-body vibration (WBV) is an exercise modality or treatment/prophylaxis method in which subjects (humans, animals, or cells) are exposed to mechanical vibrations through a vibrating platform or device. The vibrations are defined by their direction, frequency, magnitude, duration, and Biology 2021, 10, 965. https://doi.org/10.3390/biology10100965 https://www.mdpi.com/journal/biology Biology 2021, 10, 965 2 of 30 the number of daily bouts. Subjects can be exposed while performing exercises, hold postures, sitting, or lying down. Worldwide, WBV has attracted significant attention, and the number of studies is rising. To interpret, compare, and aggregate studies, the correct, complete, and consistent reporting of WBV-specific data (WBV parameters) is critical. Specific reporting guidelines aid in accomplishing this goal. There was a need to expand existing guidelines because of continuous developments in the field of WBV research, including but not limited to new outcome measures regarding brain function and cognition, modified designs WBV platforms and attachments (e.g., mounting a chair on a platform), and comparisons of animal and cell culture studies with human studies. Based on Delphi studies among experts and using EQUATOR recommendations, we have developed extended reporting guidelines with checklists for human and animal/cell culture research, including information on devices, vibrations, administration, general protocol, and subjects. In addition, we provide explanations and examples of how to report. These new reporting guidelines are specific to WBV variables and do not target research designs in general. Researchers are encouraged to use the new WBV guidelines in addition to general design-specific guidelines

Published
2021

3. Efficacy of whole-body vibration training on brain-derived neurotrophic factor, clinical and functional outcomes, and quality of life in women with fibromyalgia syndrome: a randomized controlled trial

Author

Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., Taiar, Redha, Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., and Taiar, Redha

Abstract

Whole-body vibration (WBV) is an exercise modality or treatment/prophylaxis method in which subjects (humans, animals, or cells) are exposed to mechanical vibrations through a vibrating platform or device. The vibrations are defined by their direction, frequency, magnitude, duration, and Biology 2021, 10, 965. https://doi.org/10.3390/biology10100965 https://www.mdpi.com/journal/biology Biology 2021, 10, 965 2 of 30 the number of daily bouts. Subjects can be exposed while performing exercises, hold postures, sitting, or lying down. Worldwide, WBV has attracted significant attention, and the number of studies is rising. To interpret, compare, and aggregate studies, the correct, complete, and consistent reporting of WBV-specific data (WBV parameters) is critical. Specific reporting guidelines aid in accomplishing this goal. There was a need to expand existing guidelines because of continuous developments in the field of WBV research, including but not limited to new outcome measures regarding brain function and cognition, modified designs WBV platforms and attachments (e.g., mounting a chair on a platform), and comparisons of animal and cell culture studies with human studies. Based on Delphi studies among experts and using EQUATOR recommendations, we have developed extended reporting guidelines with checklists for human and animal/cell culture research, including information on devices, vibrations, administration, general protocol, and subjects. In addition, we provide explanations and examples of how to report. These new reporting guidelines are specific to WBV variables and do not target research designs in general. Researchers are encouraged to use the new WBV guidelines in addition to general design-specific guidelines

Published
2021

4. Efficacy of whole-body vibration training on brain-derived neurotrophic factor, clinical and functional outcomes, and quality of life in women with fibromyalgia syndrome: a randomized controlled trial

Author

Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., Taiar, Redha, Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., and Taiar, Redha

Abstract

Whole-body vibration (WBV) is an exercise modality or treatment/prophylaxis method in which subjects (humans, animals, or cells) are exposed to mechanical vibrations through a vibrating platform or device. The vibrations are defined by their direction, frequency, magnitude, duration, and Biology 2021, 10, 965. https://doi.org/10.3390/biology10100965 https://www.mdpi.com/journal/biology Biology 2021, 10, 965 2 of 30 the number of daily bouts. Subjects can be exposed while performing exercises, hold postures, sitting, or lying down. Worldwide, WBV has attracted significant attention, and the number of studies is rising. To interpret, compare, and aggregate studies, the correct, complete, and consistent reporting of WBV-specific data (WBV parameters) is critical. Specific reporting guidelines aid in accomplishing this goal. There was a need to expand existing guidelines because of continuous developments in the field of WBV research, including but not limited to new outcome measures regarding brain function and cognition, modified designs WBV platforms and attachments (e.g., mounting a chair on a platform), and comparisons of animal and cell culture studies with human studies. Based on Delphi studies among experts and using EQUATOR recommendations, we have developed extended reporting guidelines with checklists for human and animal/cell culture research, including information on devices, vibrations, administration, general protocol, and subjects. In addition, we provide explanations and examples of how to report. These new reporting guidelines are specific to WBV variables and do not target research designs in general. Researchers are encouraged to use the new WBV guidelines in addition to general design-specific guidelines

Published
2021

5. Efficacy of whole-body vibration training on brain-derived neurotrophic factor, clinical and functional outcomes, and quality of life in women with fibromyalgia syndrome: a randomized controlled trial

Author

Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., Taiar, Redha, Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., and Taiar, Redha

Abstract

Whole-body vibration (WBV) is an exercise modality or treatment/prophylaxis method in which subjects (humans, animals, or cells) are exposed to mechanical vibrations through a vibrating platform or device. The vibrations are defined by their direction, frequency, magnitude, duration, and Biology 2021, 10, 965. https://doi.org/10.3390/biology10100965 https://www.mdpi.com/journal/biology Biology 2021, 10, 965 2 of 30 the number of daily bouts. Subjects can be exposed while performing exercises, hold postures, sitting, or lying down. Worldwide, WBV has attracted significant attention, and the number of studies is rising. To interpret, compare, and aggregate studies, the correct, complete, and consistent reporting of WBV-specific data (WBV parameters) is critical. Specific reporting guidelines aid in accomplishing this goal. There was a need to expand existing guidelines because of continuous developments in the field of WBV research, including but not limited to new outcome measures regarding brain function and cognition, modified designs WBV platforms and attachments (e.g., mounting a chair on a platform), and comparisons of animal and cell culture studies with human studies. Based on Delphi studies among experts and using EQUATOR recommendations, we have developed extended reporting guidelines with checklists for human and animal/cell culture research, including information on devices, vibrations, administration, general protocol, and subjects. In addition, we provide explanations and examples of how to report. These new reporting guidelines are specific to WBV variables and do not target research designs in general. Researchers are encouraged to use the new WBV guidelines in addition to general design-specific guidelines

Published
2021

6. Efficacy of whole-body vibration training on brain-derived neurotrophic factor, clinical and functional outcomes, and quality of life in women with fibromyalgia syndrome: a randomized controlled trial

Author

Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., Taiar, Redha, Universidad de Sevilla. Departamento de Educación Física y Deporte, Ribeiro, Vanessa G. C, Lacerda, Ana C. R, Santos, Jousielle M., Coelho Oliveira, Ana C., Coelho Oliveira, Ana C, Prates, Ana C.N., Flor, Jurandir, García, Bruna C. C., Tossige Gomes, Rosalina, Leite, Hércules R, Fernandes, José S. C., Arrieiro, Arthur N., Sartorio, Alessandro, Sañudo Corrales, Francisco de Borja, Sá Caputo, Danubia C., Bernardo Filho, Mário, Figueiredo, Pedro H.S., Costa, Henrique S., Cardoso, Renato F., Bastone, Alessandra C., Soares, Luana A., Mendonça, Vanessa A., and Taiar, Redha

Abstract

Whole-body vibration (WBV) is an exercise modality or treatment/prophylaxis method in which subjects (humans, animals, or cells) are exposed to mechanical vibrations through a vibrating platform or device. The vibrations are defined by their direction, frequency, magnitude, duration, and Biology 2021, 10, 965. https://doi.org/10.3390/biology10100965 https://www.mdpi.com/journal/biology Biology 2021, 10, 965 2 of 30 the number of daily bouts. Subjects can be exposed while performing exercises, hold postures, sitting, or lying down. Worldwide, WBV has attracted significant attention, and the number of studies is rising. To interpret, compare, and aggregate studies, the correct, complete, and consistent reporting of WBV-specific data (WBV parameters) is critical. Specific reporting guidelines aid in accomplishing this goal. There was a need to expand existing guidelines because of continuous developments in the field of WBV research, including but not limited to new outcome measures regarding brain function and cognition, modified designs WBV platforms and attachments (e.g., mounting a chair on a platform), and comparisons of animal and cell culture studies with human studies. Based on Delphi studies among experts and using EQUATOR recommendations, we have developed extended reporting guidelines with checklists for human and animal/cell culture research, including information on devices, vibrations, administration, general protocol, and subjects. In addition, we provide explanations and examples of how to report. These new reporting guidelines are specific to WBV variables and do not target research designs in general. Researchers are encouraged to use the new WBV guidelines in addition to general design-specific guidelines

Published
2021

7. Western blot seroindeterminate individuals for human T-lymphotropic virus I/II (HTLV-I/II) in Fortaleza (Brazil): a serological and molecular diagnostic and epidemiological approach

Author

UCL - MD/MIGE - Département de microbiologie, d'immunologie et de génétique, UCL - (SLuc) Service de microbiologie, Santos, Terezinha de Jesus Teixeira, Costa, Carlos Maurício de Castro, Goubau, Patrick, Vandamme, Anne-Mieke, Desmyter, Jan, Van Doren, Sonia, Mota, Rosa M. S., de Castro Costa, Francine Bovy, Oliveira, Ana C. S., Barreto, Vania, Gomes, A. F., Carneiro-Proietti, Anna B., de Bruin, Veralice Meireles Sales, de Sousa, Francisca C. F., Oriá, Reinaldo Barreto, UCL - MD/MIGE - Département de microbiologie, d'immunologie et de génétique, UCL - (SLuc) Service de microbiologie, Santos, Terezinha de Jesus Teixeira, Costa, Carlos Maurício de Castro, Goubau, Patrick, Vandamme, Anne-Mieke, Desmyter, Jan, Van Doren, Sonia, Mota, Rosa M. S., de Castro Costa, Francine Bovy, Oliveira, Ana C. S., Barreto, Vania, Gomes, A. F., Carneiro-Proietti, Anna B., de Bruin, Veralice Meireles Sales, de Sousa, Francisca C. F., and Oriá, Reinaldo Barreto

Abstract

How to handle Western blot (WB) seroindeterminate individuals for Human T-lymphotropic Virus 1/2 (HTLV-1/2) constitutes a challenge for blood banks and families. We made a cross-sectional study of 191 enzyme linked immunoassay (EIA) reactive individuals from the hematological center (HEMOCE) of Fortaleza (Brazil), examining their serological (WB) and molecular (PCR) diagnosis, and demographic profiles, as well as a possible association of their condition with other infectious pathologies and risk factors. Ethical institutional approval and personal consent were obtained. Out of 191 EIA reactive individuals, 118 were WB seroindeterminate and 73 were seropositive for HTLV-1/2. In the PCR analysis of 41 WB seroindeterminate individuals, 9 (22%) were positive and 32 (78%) were negative for HTLV-1/2. The demographic analysis indicated a trend towards a predominance of males among the seroindeterminate individuals and females in the seropositive ones. The seroindeterminate individuals were younger than the seropositive ones. We did not find any association of these conditions with syphilis, Chagas disease or HIV or hepatitis, and with risk factors such as breast-feeding, blood transfusion, STD (syphilis) and IDU.

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results